Results 251 to 260 of about 1,861,984 (306)

Multimodal single cell-resolved spatial proteomics reveal pancreatic tumor heterogeneity. [PDF]

open access: yesNat Commun
Xu Y   +16 more
europepmc   +1 more source

Rare Pancreatic Tumors

Magnetic Resonance Imaging Clinics of North America, 2018
Although pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer, a variety of more rare benign and malignant tumors of the pancreas have been identified. Computed tomography (CT) and MR imaging are the primary modalities for further noninvasive characterization of these lesions. This review presents an approach to imaging of rare
Anup S, Shetty, Christine O, Menias
openaire   +2 more sources

Cystic Pancreatic Tumors

Magnetic Resonance Imaging Clinics of North America, 2018
Cystic pancreatic lesions are common and often incidentally detected on cross-sectional examinations of the abdomen. Most lesions are asymptomatic and benign. However, some carry a significant risk of malignant degeneration, so correct identification, complete characterization, and adequate follow-up/management of these lesions are paramount.
Kristine S, Burk   +2 more
openaire   +2 more sources

Tumor lysis pancreatitis

Medical and Pediatric Oncology, 1979
AbstractRapid tumor lysis may produce acute complications including systemic metabolic disturbances and hemorrhage in sites involved by tumor. We have observed two cases of acute pancreatitis induced by the lysis of lymphoma that involved the pancreas. This previously unreported cause of pancreatitis must be added to the list of potential complications
R J, Spiegel, I T, Magrath
openaire   +2 more sources

Pancreatic hepatocellular tumor

Pancreatology, 2005
Hepatocellular differentiation of pancreatic cells has been observed under certain conditions in several species, including humans. Their cell of origin and biology has remained controversial. Generally, these lesions have been considered a degenerative process.
Fumiaki, Nozawa, Parviz M, Pour
openaire   +2 more sources

Pancreatic neuroendocrine tumors

Disease-a-Month, 2013
Pancreatic neuroendocrine tumors (PNETs) have an incidence of approximately 1 per 100,000 individuals per year, and account for 1–2% of all pancreatic tumors. The annual incidence in the United States is about 3.65 per 100,000 population. Although they may manifest at any age, they most often occur in the fourth to sixth decades of life. Most PNETs are
Thiruvengadam, Muniraj   +4 more
openaire   +4 more sources

Pancreatic tumors in children

Pediatric Surgery International, 1996
Pancreatic tumors rarely present in childhood. Diagnostic difficulty and inappropriate treatment may occur due to the variable clinical appearance of the illness. A 26-year audit (1968-1994) at this institution showed five patients ranging in age from 5 to 14 years who were operated upon for pancreatic tumors, four of which were malignant. In two cases
J, Grochowski   +3 more
openaire   +2 more sources

Pancreatic Endocrine Tumors

Pathology - Research and Practice, 1988
In this review the current state of our understanding of endocrine tumors of the pancreas is considered. It is based on the experience with a series of 365 tumors. The first part of the article focuses on origin and classification, markers, frequency, criteria of malignancy as well as general structural features of the pancreatic endocrine tumors.
G, Klöppel, P U, Heitz
openaire   +2 more sources

Pancreatic endocrine tumors

Current Opinion in Oncology, 2001
Pancreatic endocrine tumors are rare but have long held a fascination for clinicians because of the physiologic derangements that they can cause, and the dramatic corrections that can be achieved by appropriate management. In the year reviewed in this article, the literature again demonstrated the ongoing interest and research in this area.
J, Chun, G M, Doherty
openaire   +2 more sources

Home - About - Disclaimer - Privacy